Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
GLP-1s Rewrite the Comorbidity Playbook In the commercial market, new to brand GLP-1 prescriptions have surged more than 700% over the past four years, reflecting both their growing popularity and expanding evidence base
These developments raised several questions, including concerns about the direct and indirect impacts of these anti-obesity drugs on bone metabolism, particularly in PwO experiencing a massive amount of weight loss
10.1007/BF02064202 74 LeechC
GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women
US$ 27.11
US$ 27.22
US$ 27.18
US$ 28.31
US$ 20.84
US$ 21.07
US$ 23.62
US$ 29.27
